Surgo Health Launches Nation’s Most Comprehensive Youth Mental Health Tracker
The Youth Mental Health Tracker, developed by Surgo Health with funding from Pivotal and SHOWTIME/MTV Entertainment Studios, reveals new data...
Clinical Trial
Wavegate Corporation Announces $26 Million Series A Funding Round Led by UCEA Capital Partners Ltd.
LAKE CHARLES, La., Dec. 10, 2024 /PRNewswire/ -- Wavegate Corporation, a pioneering developer of neuromodulation technology for chronic pain management,...
New ALS Association-Led Research Finds Specialists Diagnose ALS Twice as Fast as General Neurologists
Groundbreaking thinkALS™ Tool Empowers Providers to Identify and Refer Patients Quicker ARLINGTON, Va., Dec. 10, 2024 /PRNewswire/ -- It can take...
Echo IQ Signs Integration Agreement With Flagship US Hospital
Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA Integration follows successful trial of EchoSolv-AS by Beth Israel...
Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress
WELLINGTON, FL and HIGHLANDS RANCH, CO / ACCESSWIRE / December 10, 2024 / Cellev8 Nutrition Inc. (OTC Pink:CELV) and Vivos...
Neuropathy Action Foundation Launches White Paper on the Promise and Potential Hazards of Artificial Intelligence (AI) for Neuropathy
NAF calls for increased awareness and advocacy around use of AI to prevent potential abuses SANTA ANA, Calif., Dec. 10,...
Lindus Health Releases “All-in-One Cardiovascular CRO” Offering for Clinical Trials Serving Cardiovascular Health
NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science...
DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder
MMJ Submits FDA Investigational New Drug Application for Cannabis-Derived Drug WASHINGTON, DC / ACCESSWIRE / December 10, 2024 / MMJ...
Dermata Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne
- This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne --...
MIRA Pharmaceuticals Validates Ketamir-2’s Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End
Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain MIAMI, FL / ACCESSWIRE /...
Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
~ Supply Chain Now Fully Secure for PF614-MPAR ~ SAN DIEGO, CA / ACCESSWIRE / December 10, 2024 / Ensysce...
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections
Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals KNOXVILLE, TN / ACCESSWIRE / December 10, 2024 / VisiRose, a...
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
Press Release – No. 12 / 2024 Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide...
Longer-term Novartis Kisqali® NATALEE data show durable reduction in distant recurrence in broad population of patients with early breast cancer
Reduction in distant recurrence consistently deepened beyond 3-year Kisqali treatment duration in patients with node-positive (N+) and high-risk node-negative (N0)...
H1 Partners with CTI to Streamline Clinical Trial PI and Site Selection for More Inclusive and Efficient Trials
Leading Contract Research Organization integrates H1’s Trial Landscape platform to optimize global site selection, enhance diversity efforts, and streamline operational...
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without...
ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer
Data from Phase 1b/2 clinical trial to be presented at 2024 San Antonio Breast Cancer Symposium (SABCS) show encouraging clinical...
New MammoCAT Advanced Mammography System Offers Substantial Improvements in Dense Breast Imaging
Fischer Imaging Delivers MammoCAT to Johns Hopkins University for Preclinical TestingATLANTA, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Mammograms are one...
Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies
New collaboration showcases successful integration of Ori's IRO Platform with Cue and Lovo processing systems to enhance efficiency in CGT...
Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium
HOUSTON, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation...